Cellular Cancer Immunotherapy in the Liver Transplant Population for HCC: An Attractive Therapeutic Option for the Next Decade. Yu D, Li S, Chen H, Wang L, et al. Clin Transplant 2025;39:e70313.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yu D, Li S, Chen H, Wang L, et al. Cellular Cancer Immunotherapy in the Liver Transplant Population for HCC: An Attractive Therapeutic Option for the Next Decade. Clin Transplant 2025;39:e70313.
PMID: 40944927